Global Pregnancy Detection Kits Market to grow at a CAGR of 5.86% during the period 2016 - 2020; Finds New Report

Report forecast the global pregnancy detection kits market to grow at a CAGR of 5.86% during the period 2016-2020.

A pregnancy detection kit is used for the determination of human chorionic gonadotropin (hCG) hormone in urine samples, for obtaining a visual and qualitative result that leads to an early detection of pregnancy. The global pregnancy detection kit market is driven by factors such as rising demand for POC testing, fast and self-contained tests, growing incidence of gynecological disorders, and improved availability of decentralized diagnostic tests over time-consuming laboratory tests.

The report covers the present scenario and the growth prospects of the global pregnancy detection kits market 2016-2020. To calculate the market size, the report considers the revenue generated from the retail sale of pregnancy detection kits.

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

According to the report, demand for POC testing will boost growth in the pregnancy detection kits market. With the fast-paced lifestyle, the need for instantaneous pregnancy test results has increased. This has resulted in continuous improvements in the products, which help provide a prompt diagnosis at a desired time and place. Immediate results reduce or eliminate the anxiety associated with pregnancy detection and the need to visit a doctor or clinic.

Further, the report states that midstream pregnancy detection kits are the most expensive pregnancy testing kits available in the market. The high price is due to the use of advanced technologies for getting precise results instantly. As a result, many consumers choose to use other formats of pregnancy tests such as the card or the strip, as they provide the same basic results with an acceptable level of accuracy, but are significantly cheaper than the midstream format. This is especially true in developing economies, where the penetration of this format is extremely low due to low affordability.

Global Pregnancy Detection Kits Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global pregnancy detection kits market: Alere, Church & Dwight, Prestige Brands, and Quidel.

Other Prominent Vendors in the market are: Boots Pharmaceuticals, Confirm BioSciences, CVS Health, Germaine Laboratories, KIP Diagnostics, Map Diagnostics, Piramal Healthcare, Philippine Blue Cross Biotech, Princeton BioMeditech, Rite-Aid, and Mankind Pharma.

Market driver

• Rise in popularity of midstream format
• For a full, detailed list, view our report

Market challenge

• High price of midstream kits
• For a full, detailed list, view our report

Market trend

• Advances in product offerings
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 60 pages and 30 Exhibits “Global Pregnancy Detection Kits Market 2016 - 2020” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Geographical segmentation, Distribution channel, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Other prominent vendors, Appendix.

For more information Visit at: http://mrr.cm/3dg

Related Reports;

Global Hemophilia Drugs Market 2016-2020 - Visit at - http://mrr.cm/3dM

Global Breath Analyzers Market 2016-2020 - Visit at - http://mrr.cm/3dQ

Global Animal Antibacterial and Antibiotics Market to grow at a CAGR of 6.5% during the period 2016 - 2020; Finds New Report

Report forecast the global animal antibacterial and antibiotics market to grow at a CAGR of 6.5% during the period 2016-2020.

Antibacterial and antibiotic drugs are used to treat various conditions that affect animals such as companion animals, swine, cattle, horses, and fish. These drugs are also used to accelerate the growth of animals, especially in North America and Europe. However, an overuse of antibiotics has led to the development of antibiotic-resistant strains of microorganisms. This is a worrying trend as the resistant microbes could be transferred to humans through the consumption of milk or meat.

The report covers the present scenario and the growth prospects of the global animal antibacterial and antibiotics for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

According to the report, demand for protein-rich diet will drive growth in the market. Globally, animal products such as milk, eggs, and meat serve a large proportion of the human population. The increase in population is fueling the growth in the demand for food, including animal-based food. Further, the rise in urbanization has created a shift in consumption patterns. Demand for nutrient-dense foods such as animal-based meat and related food items such as milk, egg, and dairy products is on a rise.

Further, the report states that stringent regulatory guidelines for obtaining market approvals of animal drugs are a major hindrance to market growth. In the EU, distinct product supply rules for animal products and language barriers among member states affect the efficient and timely distribution of these drugs. For instance, in Italy, the regulations for the animal healthcare sector are more stringent than for the human healthcare sector, which hinders the regulatory approval process.

Global Animal Antibacterial and Antibiotics for 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global animal antibacterial and antibiotics market: Zoetis, Merck Animal Health, Merial, Elanco, and Bayer HealthCare

Other Prominent Vendors in the market are: Animal Medics, Biogénesis Bagó, Bio-Vet, Boehringer Ingelheim Vetmedica, Ceva Santé Animale, Dechra Pharmaceuticals, ECO Animal Health, Huvepharma, Indian Immunologicals, Lillidale Animal Health, Mobedco-Vet (The Arab Pesticides & Veterinary Drugs), Neogen, Norbrook, Orion, Phibro Animal Health, Vétoquinol, Virbac, and Vitafor.

Market driver

• Demand for protein-rich diet
• For a full, detailed list, view our report

Market challenge

• Lengthy regulatory approval process
• For a full, detailed list, view our report

Market trend

• Industry-academia collaborations
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 71 pages and 48 Exhibits “Global Animal Antibacterial and Antibiotics Market 2016 - 2020” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Veterinary drug approval process, Antibacterial: Overview, Market segmentation by chemical class, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://mrr.cm/3de

Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare

Global Condom Market is expected to reach US $9.6 billion till 2021; Finds New Report

The worldwide condom market is expected to reach approx. US $9.6 billion till 2021.

Condoms are the barrier type contraceptive that are designed to eliminate the actual contact between sexual organs. Condoms contain a physical barrier that stops the transfer of sexual fluids required for insemination.

The report “Global Condom Market – Strategic Assessment and Forecast till 2021” considers the present scenario and growth aspect of worldwide condom market. The report includes the market growth drivers, trends, and restraints. The report gives a market segmentation

By Type

• Male Condom
• Female Condom

By Material

• Latex
• Non- Latex
• Coatings

By Geography

• North America
• EMEA
• APAC
• Latin America

By Country

• Africa
• Australia
• Australia
• Brazil
• Canada
• Europe
• India
• Japan
• Malaysia
• Middle East
• North Africa
• Sub Saharan Africa
• Thailand
• US

Condom Market – Market Size and Dynamics

The research Analyst at publisher predicts the worldwide condom market to reach approx. US $9.6 billion with a CAGR of more than 8.2% till 2021. The sales volume of female condom is on a higher note and is expected to grow at a CAGR of 10.9%. Whereas the sales volume of male condoms can grow at a CAGR of 9.1% over the period 2015-2021. The global condom market analysis has come up with detailed study of the revenue generated by the market. The global condom manufacturing industry has seen a dramatic shift in the consumption and sales of the condoms made up of different materials. The continuous innovations in both male and female type condoms is attracting more consumers hence increasing the sale as well as revenue. Latex condoms emerged to be the most popular choice of male contraceptive. The latex remained to be the most prominent one with a market share of around 95% in terms of revenues generated.

Condom Market- Trends, Drivers and Restraints

This market research report provides market overview of the factors driving and restraining the growth of the market. The report also outlines the key trends emerging in the market that will contribute to the growth of Worldwide Condom Market during the forecast period. Increased planning for population control and family planning measures by various NGOs and Government has triggered the condom market growth. On addition to it the introduction of female condoms has created a new market segment itself for the worldwide condom market. Further more comprehensive sex education for the most active demographic segment such as the teenagers is a major driver for the condom market growth. The report gives a clear description of all the factors driving the market. Also rise in innovative condom designs and luxury packaging of the condoms, giving a brand image, have been some of the emerging trends mentioned in the report. The report includes all the trends and challenges for the market for the next five years. The report gives a porter’s five force analysis.

Condom Market – Geographic Analysis

The report includes the market analysis of different regions such as North America, Latin America, APAC, and Europe and MEA. The report outlines the major market share holder and the market size analysis of all the regions. APAC region being accounted the most populous region can be a major contributor in global condom market. The condom market in APAC region is expected to have a market revenue more than US$ 3 million. APAC is the largest market share holder in worldwide condom market. Condoms remain to be a major contraceptive method, primarily in Africa and Europe. North America representing some of the most advanced economies in the world is a major market for contraceptives including condoms, on account of well formulated sex education, efficient distribution channels.

The report also provides the revenue forecast of each region featuring the key countries.

Condom Market – Key Vendors and Market Share

This market research profiles the major companies in the Global Condom Market and also provides the competitive landscape and market share of key the players. The report covers the entire market outlook regarding the value chain operating within the market.

The Key vendors included in the report are

• Ansell
• Reckitt Benckiser Group
• The Female Health
• Karex Berhad

Other prominent vendors are

• Medical-Latex (DUA)
• Innolatex
• HLL Lifecare Limited
• Fuji Latex
• Convex Latex Pvt. Ltd.
• BILLY BOY
• MTLC Latex
• Sagami Rubber Industries
• Shandong Ming Yuan Latex
• Thai Nippon Rubber Industry – TNR

Why should you buy Global Condom Market Report?

The report gives reasonable answers for the following questions which leads you to know the in- depth market analysis such as

1) How has the market been performing and what are some of the current changes which are expected to change the landscape in the coming years?

2) What are the various factors that can affect the market and in what way over the next few years?

3) What are the emerging trends and challenges for the market over the next five years?

4) Which regions are going to have the largest market share and what are the factors propelling the market growth in that region?

5) What are the market size and growth forecast of the key countries?

6) Which companies are the key vendors in the market?

7) What are the strategies used by the top vendors, and what are the opportunities to grow?

8) Which companies are the emerging vendors in the market?

Spanning over 122 pages and 90 Exhibits “Global Condom Market - Strategic Assessment and Forecast Till 2021” report covers Research Methodology, Executive Summary, Report Coverage, Introduction, Key Market Trends, Key Market Drivers, Key Market Challenges, Worldwide Condom Market, Segmentation by Type / Grade, Segmentation by Material, Segmentation by Geography, Condom Market Size and Analysis, EMEA: Condom Market Size and Analysis, North America: Condom Market Size and Analysis, Latin America: Condom Market Size and Analysis, Competitive Landscape, Key Vendor Analysis, Other Prominent Vendors, Appendix. This report Covered Companies - Ansell, Reckitt Benckiser Group, The Female Health, Karex Berhad, Medical-Latex (DUA), Innolatex, HLL Lifecare Limited, Fuji Latex, Convex Latex Pvt. Ltd., BILLY BOY, MTLC Latex , Sagami Rubber Industries, Shandong Ming Yuan Latex, Thai Nippon Rubber Industry – TNR.

For more information Visit at: http://mrr.cm/3QR

Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare

Global Medical Aesthetics 2016 Market Report; Launched via MarketResearchReports.com

2016 Global Medical Aesthetics Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Medical Aesthetics industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

The report firstly introduced the Medical Aesthetics basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Medical Aesthetics industry; 3.) the North American Medical Aesthetics industry; 4.) the European Medical Aesthetics industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

Spanning over 153 pages “Global Medical Aesthetics Market Research Report 2016” report covers Medical Aesthetics Industry Overview, Asia Medical Aesthetics Industry, North American Medical Aesthetics Industry, Europe Medical Aesthetics Industry Analysis, Medical Aesthetics Marketing Channels and Investment Feasibility, Global Medical Aesthetics Industry Conclusions.

For more information Visit at: http://mrr.cm/3Qz

Related Reports:

Global Medical Videoscope Market Research Report 2016 - Visit at - http://mrr.cm/3QK

Global Ophthalmology Cataract Surgery Devices Market Research Report 2016 - Visit at - http://mrr.cm/3Qr

Global Sports Medicine Market Research Report 2016 - Visit at - http://mrr.cm/3QH

Global Intragastric Balloons Market is expected to reach at a CAGR of more than 7.01% till 2021; Finds New Report

The global intragastric balloons market is expected to grow at a CAGR of more than 7.01% till 2021.

Global Intragastric Balloons Market - Strategic Assessment and Forecast till 2021 market research report considers the present scenario of worldwide intragastric balloons market and forecasts the growth of the market till 2021.

Intragastric balloons are the saline-filled silicone balloons placed in the stomach for a span of months and limits intake of food by giving the feeling of satiety. These balloons permit patients to sense fullness, controls hunger, delays gastric emptying by altering gut hormones and peptides thus reducing food intake ultimately.

The research report gives an in- depth analysis of the market growth, trends, driver and restraints associated with it. The report gives a detailed analysis of the intragastric balloons

By Geography

• Americas
• Europe Middle East and Africa (EMEA)
• Asia-Pacific (APAC)

By Countries

• Africa
• Australia
• Brazil
• Canada
• China
• France
• Germany
• India
• Italy
• Japan
• Korea
• Middle East (Saudi Arabia, Qatar, Kuwait)
• New Zealand
• Spain
• UK
• US

The report also provides market share and profiles the key vendors operating in the Worldwide Intragastric Balloons Market and also provides the detailed competitive landscape of key players.

Intragastric Balloons Market – Market size and Dynamic

The market research analyst at publisher expects the global intragastric balloons market to reach approx. US$198.56 million by 2021, growing at a CAGR of 7.01% during the forecast period 2016-2021. A large portion of the US healthcare expenditure is spent on programmes related to chronic diseases like obesity. Owing to this, the adoption of intragastric balloons is expected to propel in the U.S. to manage obesity. Europe, Middle East, and Africa (EMEA) accounts for the major share of the market.

Intragastric Balloons Market – Trends and Drivers

This market research report provides market overview of the factors driving and restraining the growth of the market. The report also outlines the key trends emerging in the market that will contribute to the growth of Intragastric Balloons Market during the forecast period. Today, intragastric balloons are used as treatment for obesity as a pre-emptive therapy, a metabolic therapy, or a primary therapy. Intragastric balloons help in weight loss and helps in recovering metabolic diseases. Factors such as large obese population, unhealthy lifestyle, short hospital stay, short recovery time, and low price of intragastric ballooning globally are driving the growth of the market.

There a short- term and long term risks and adverse effects associated with the use of intragastric balloons which is one of the major impeding challenges for the intragastric balloons market.

Intragastric Balloons Market – Geographical Analysis

The report includes the market analysis of different regions such as Americas, APAC, and Europe and MEA. The report outlines the major market share holder and the market size analysis of all the regions. Europe, Middle East and Africa (EMEA) is expected to continue dominating the intragastric balloons market in near future with a market share of approx.. 62% in 2021. In EMEA, the EU5 dominates the market with a collective share of about 91.5% in 2015 The US is the nascent market for intragastric ballooning with the first US FDA approval of intragastric ballooning in mid-2015. Mexico is likely to spur the growth of the intragastric balloons market in the Latin American region.

Intragastric Balloons – Key Market Share and Vendor Analysis

This market research profiles the major companies in the Worldwide Intragastric Ballons Market and also provides the competitive landscape and market share of key the players. The report covers the entire market outlook regarding the value chain operating within the market.

Major Players in the market

• Apollo Endoscopy Inc.
• Spatz FGIA Inc.
• Allurion Technologies Inc.
• ReShape Medical Inc.
• Hélioscopie SA
• Obalon Therapeutics Inc.

Other Prominent Vendors are

• Silimed Inc.
• Endalis
• Obalon Therapeutics Inc
• BAROnova Inc.
• Districlass Medical SA
• MEDSIL
• PlenSat, Inc.
• LIFE PARTNERS EUROPE
• Medicone
• Fengh Medical
• Phagia Technologies, Inc.
• Shandong Institute of Medical Instruments
• Tulip Medical

Why should you buy Intragastric Balloons Market Report?

The report gives reasonable answers for the following questions which leads you to know the in- depth market analysis such as

1) How has the market been performing and what are some of the current changes which are expected to change the landscape in the coming years?

2) What are the various factors that can affect the market and in what way over the next few years?

3) What are the emerging trends and challenges for the market over the next five years?

4) Which regions are going to have the largest market share and what are the factors propelling the market growth in that region?

5) Which companies are the key vendors in the market?

6) What are the strategies used by the top vendors, and what are the opportunities to grow?

7) Which companies are the emerging vendors in the market?

Spanning over 84 pages and 41 Exhibits “Global Intragastric Balloons Market - Strategic Assessment and Forecast Till 2021” report covers Research Methodology, Executive Summary, Report Coverage, Market Research Methodology, Introduction, Market Landscape, Key Market Growth Drivers, Key Market Restraints, Key Market Trends, Key Market Growth Opportunity, Value Chain Analysis, Evidence-based Research Studies, Worldwide Intragastric Balloons Market by Geography, Intragastric Balloons Market in the Americas, Intragastric Balloons Market in EMEA, Intragastric Balloons Market in APAC, Changing Regulatory Landscape in Europe, Vendor Landscape, Market Share Analysis, Competitive Landscape, Key Vendor Analysis, Summary of the Report, Appendix. This report Covered Companies - Apollo Endoscopy Inc., Spatz FGIA Inc., Allurion Technologies Inc., ReShape Medical Inc., Hélioscopie SA, Obalon Therapeutics Inc., Silimed Inc., Endalis, Obalon Therapeutics Inc, BAROnova Inc., Districlass Medical SA, Medsil, PlenSat, Inc., Life Partners Europe, Medicone, Fengh Medical, Phagia Technologies, Inc., Shandong Institute of Medical Instruments, Tulip Medical

For more information Visit at: http://mrr.cm/3Qa

Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare

Global 3D Printing Medical Devices 2016 Market Report; Launched via MarketResearchReports.com

2016 Global 3D Printing Medical Devices Industry Report is a professional and in-depth research report on the world's major regional market conditions of the 3D Printing Medical Devices industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

The report firstly introduced the 3D Printing Medical Devices basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The report includes six parts, dealing with: 1.) basic information; 2.) the Asia 3D Printing Medical Devices industry; 3.) the North American 3D Printing Medical Devices industry; 4.) the European 3D Printing Medical Devices industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

Spanning over 153 pages “Global 3D Printing Medical Devices Market Research Report 2016” report covers Printing Medical Devices Industry Overview, Asia 3D Printing Medical Devices, North American 3D Printing Medical Devices Industry, Europe 3D Printing Medical Devices Industry Analysis, 3D Printing Medical Devices Marketing Channels and Investment Feasibility, Global 3D Printing Medical Devices Industry Conclusions.

For more information Visit at: http://mrr.cm/3QV

Related Reports:

Global Immunoassay Market Research Report 2016 - Visit at - http://mrr.cm/3Qj

Global Chiral Separation Column Market Research Report 2016 - Visit at - http://mrr.cm/3Q9

Global Active Pharmaceutical Ingredient (API) Market Research Report 2016 - Visit at - http://mrr.cm/3QC

Healthcare Staffing Market in US is expected to reach at a CAGR of 13.70% by 2021; Finds New Report

The Healthcare Staffing Market in US is expected to grow at a CAGR of 13.70% by 2021

Healthcare staffing or medical staffing is a process to fill medical positions, both temporary and permanent, in various healthcare organizations. Such as acute care hospitals and non-acute care hospitals, government facilities, outpatient clinics, public and charter schools, physician practice groups, ambulatory care facilities, retailers, among other healthcare settings.

The report “Healthcare Staffing Market in US - Strategic Assessment and Forecast 2021” considers the present scenario and growth aspect of Healthcare Staffing market in the US and strategic assessment of the market for the period 2015-2021.The report includes the market growth drivers, trends, and restraints. The report gives a market segmentation

By End-user Segment

• Hospitals
• Pharmaceutical Client
• Other Healthcare Provider
• Government Agencies
• Others

By Staffing Services in US

• Nursing staffing services
• Locum tenens staffing services
• Allied health staffing services

Healthcare Staffing Market in US - Market Size and Forecast

Staffing agencies are burdened with finding the right choice for the suitable position available with their client employer. The earlier notion that a staffing company only provides replacement of the absentee employee with temporary ones is no more valid. The industry has grown and now takes a more strategic role in offering a variety of workforce solutions and services to their client employer. In the US, the staffing industry impacts the economy through its service offerings and offers jobs and career opportunities to about 16 million employees per year.

The Healthcare Staffing Market in US is expected to grow at a CAGR of 13.70% by 2021. The Market Research Analyst predicts that the Healthcare staffing market in US is expected to reach $28.3 billion in terms of revenue. Healthcare staffing companies are witnessing huge demands because of the increased population in US.

Healthcare Staffing Market in US – Trends, Drivers & Restraints

The healthcare industry in the US is witnessing a shortage of nurses in the country. There is a growing demand for nurses in hospital and community services. According to the US Bureau of Labor Statistics, the demand for registered nurses in the country is expected to grow by 14%-16% by 2021 from 2015. Thus the shortage of nurse and the growing demand of nurses in US is one of the major factor for driving the market.

One of the major reasons behind this increased demand is the fact that a significant number of nurses are getting retired over the next few years. About 55% of the overall nursing workforce, currently in service, in the US, is above 50 years of age. According to the US Bureau of Labor Statistics, over 526,800 nurses will be retiring over the forecast year in the country. Hence there will be a huge requirement of registered nurses. This requirement to fulfil the gap of the manforce requirement is one of the key emerging trends. According to the US Bureau of Labor Statistics and the US Department of Labor, the overall nurse employment is set to increase from 2.86 million in 2012 to 3.44 million by 2022. Also The increase in the demand for home healthcare workforce such as dieticians, nurses, nutritionists, therapists, and home care aides among others will drive the demand for temporary staffing in the market.

Limited pool of qualified healthcare professionals and government regulations on healthcare recruitment are the major challenges for Healthcare Staffing market in US.

The report also provides the Porter’s five forces analysis along with a description of each of the forces and its impact on the market.

Healthcare Staffing Market in US- Market Share and Vendors

The report Healthcare Staffing Market in US also provides the competitive landscape of the key players. The report covers the players operating in the entire value chain of the market. The major players identified within the report are AMN Healthcare, CHG Healthcare, Cross Country Healthcare, Jackson Healthcare and Maxim Healthcare.

The emerging vendors included in the report are Accountable Healthcare Staffing, Aya Healthcare, Favorite Healthcare Staffing, InGenesis, Healthcare Staffing Services, Medical Solutions, MedPartners, Parallon Workforce Management Solutions (HCA), Soliant Health (Adecco), trustaff, Vista Staffing Solutions

Spanning over 111 pages and 70 Exhibits “Healthcare Staffing Market in US - Strategic Assessment and Forecast Till 2021” report covers Research Methodology, Executive Summary, Report Coverage, Market Research Methodology, Market Landscape, Key Market Growth Drivers, Key Market Trends, Key Market Restraints, Staffing Process Analysis, US Healthcare Staffing Market, Market Segmentation by Staffing Services, Vendor Landscape, Emerging Vendors, Key Vendor Analysis, Summary of the Report, Summary of Figure, Appendix. This report Covered Companies - AMN Healthcare, CHG Healthcare, Cross Country Healthcare, Jackson Healthcare, Maxim Healthcare, Accountable Healthcare Staffing, Aya Healthcare, Favorite Healthcare Staffing, InGenesis, Healthcare Staffing Services, Medical Solutions, MedPartners, Parallon Workforce Management Solutions (HCA), Soliant Health (Adecco), trustaff, Vista Staffing Solutions.

For more information Visit at: http://mrr.cm/3QE

Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare

Global Neuromodulation Market is expected to reach US$ 5 Billion by 2021; Finds New Report

The global neuromodulation market is poised to cross US$ 5 Billion mark by 2021. Neuromodulation is a technology that acts directly upon nerves. It is the alteration-or modulation-of nerve activity by delivering electrical or pharmaceutical agents directly to a target area. Neuromodulation devices and treatments are life changing. They affect every area of the body and treat nearly every disease or symptom from headaches to tremors to spinal cord damage to urinary incontinence. With such a broad therapeutic scope, and significant ongoing improvements in biotechnology, the neuromodulation is poised as a major growth industry for the next decade.

The market growth is attributed to factors such as an increased adoption of neuromodulation devices, ageing population, rising prevalence of diseases relevant to neuromodulation, technological advancements and deal making activity globally. However, the factors such as regulatory standards and compliance, negative social perception and a dearth of skilled neurosurgeons are restraining the growth of neuromodulation market globally.

By Technology Neuromodulation Market Analysis - In terms of technology, Spinal cord stimulation (SCS) is the largest segment of the market and is mostly indicated for treatment of chronic pain. Deep brain stimulation (DBS) represents the second largest segment within the neuromodulation market being followed by Sacral nerve stimulation (SNS) at the third spot in 2015. The VNS segment stands at the fourth spot with around XX% share of the neuromodulation market in 2015.

By Applications Neuromodulation Market Analysis - In terms of applications, Chronic pain is the leading application segment of the neuromodulation market. The urinary and fecal incontinence market is the second largest application segment of the neuromodulation market. Refractory epilepsy holds third highest share of the neuromodulation market in 2015 being followed by Parkinson’s disease. The Gastroparesis and Essential Tremor applications segment are competing closely with each other to grab maximum share of the pie.

Neuromodulation Market Regional Analysis - Geographically, North America is at the forefront of neuromodulation innovation, accounting for lion’s share of the global neuromodulation market in 2015. Europe is the second leading region for neuromodulation market and it is likely to remain at this position throughout the forecasting period. Japan captured third highest share of the global neuromodulation market in 2015. While China and brazil are competing closely with each other to grab maximum share of the market. In Latin American countries, Mexico and Brazil represent significant market potential for neuromodulation manufacturers.

Neuromodulation Market Company Analysis - Medtronic has been the dominant market player in the global neuromodulation market. However, it is facing increased competition from other players operating in the neuromodulation market. Boston Scientific is the second leading player for neuromodulation market capturing XX% share in 2015. St. Jude Medical is the third largest player by market share in the overall neuromodulation market. While, LivaNova (Cyberonics) and Nevro Corp. stands at the fourth and fifth spot respectively in the global neuromodulation market space.

Neuromodulation Market (by Technology, Applications Segment, Region and Company) and Forecast to 2021 - Global Analysis report provides a comprehensive assessment of the fast-evolving, high-growth global neuromodulation market. This report covers various aspects of the neuromodulation market including Technological Segment, Applications Segment, Regional Market, Company Sales and Product Portfolio Analysis, Major Deals in Neuromodulation Market landscape, and Growth Drivers and Challenges influencing global neuromodulation market.

This 156 Page report with 63 Figures and 8 Tables has been analyzed from 7 viewpoints:

1. Global Neuromodulation Market and Forecast (2010 - 2021)

2. By Technology - Global Neuromodulation Market and Forecast (2010 - 2021)

3. By Applications Segment - Global Neuromodulation Market and Forecast (2010 - 2021)

4. Neuromodulation Market and Forecast - Regional Analysis (2010 - 2021)

5. Global Neuromodulation Market and Forecast - Company Analysis (2010 - 2021)

6. Global Neuromodulation Market - Major Deals

7. Global Neuromodulation Market - Driving Factors and Challenges

Global Neuromodulation Market and Forecast - 5 Technological Segments Covered

1. Spinal Cord Stimulation (SCS)

2. Deep Brain Stimulation (DBS)

3. Sacral Nerve Stimulation (SNS)

4. Vagus Nerve Stimulation (VNS)

5. Other Technologies

Global Neuromodulation Market and Forecast - 11 Applications Segment Covered

1. Chronic Pain

2. Urinary and Fecal Incontinence

3. Parkinson’s Disease

4. Refractory Epilepsy

5. Essential Tremor

6. Dystonia

7. Gastroparesis

8. Treatment Resistant Depression (TRD)

9. Obsessive Compulsive Disorder(OCD)

10. Intractable chronic migraine (ICM)

11. Other Applications

Neuromodulation Market and Forecast - 6 Regions Covered

1. North America

2. Europe

3. Japan

4. China

5. Latin America

6. Rest of the World

Global Neuromodulation Market and Forecast - 6 Companies Covered

1. Medtronic

2. Boston Scientific

3. St. Jude Medical

4. LivaNova (Cyberonics)

5. Nevro Corp

6. Others

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Spanning over 156 pages “Neuromodulation Market (by Technology, Applications Segment, Region and Company) and Forecast to 2021 - Global Analysis” report covers Executive Summary, Global - Neuromodulation Market and Forecast (2010 - 2021), Global - Neuromodulation Market Share and Forecast (2010 - 2021), Neuromodulation Market and Forecast - By Technology (2010 - 2021), Neuromodulation Market and Forecast - By Applications (2010 - 2021), Neuromodulation Market and Forecast - Regional Analysis (2010 - 2021), Neuromodulation Market and Forecast - Company Analysis (2010 - 2021), Global Neuromodulation Market - Major Deals (2011 - 2016), Global Neuromodulation Market - Growth Drivers, Global Neuromodulation Market - Challenges. This report Covered Companies - Medtronic, Boston Scientific, St. Jude Medical, LivaNova, Nevro Corp.

For more information Visit at: http://mrr.cm/3Qx

Find all Therapeutic Reports at: http://www.marketresearchreports.com/therapeutic

Global Molecular Diagnostics Market is expected to reach US$ 11.4 billion by 2022; Finds New Report

Global Molecular Diagnostics Market - Focus on Infectious Diseases (HPV/Chlamydia/Gonorrhea) & Genetic Testing (HLA) - Industry Outlook 2022, there has been unprecedented rise in sexually infected diseases such as Chlamydia and Gonorrhea, particularly in the US. CT/NG is most prevalent sexually transmitted diseases (STD) in the US with consistent rise in the number of Chlamydia and Gonorrhea cases. The Government has also recommended regular screening for patients belonging to two of the major segments of the molecular diagnostics market: HPV and CT/NG.

Global Molecular Diagnostics Market - Focus on Infectious Diseases (HPV/Chlamydia/Gonorrhea) & Genetic Testing (HLA) - Industry Outlook 2022 provides an in-depth analysis of global molecular diagnostics market which is estimated to be valued at US$ 6.7 billion in the year 2016 and projected to reach US$ 11.4 billion by 2022, growing at a CAGR of 9.3% in the period 2016-22. The report focuses on Infectious Diseases (HPV/Chlamydia/Gonorrhea) & Genetic Testing (HLA). The infectious diseases segment dominates the molecular diagnostics market by application with HPV dominating in virology segment and CT/NG in bacteriology segment. It provides details on current and forecasted scenario of each of aforementioned diseases.

Growth of the market is driven by prevalence of reproductive infectious diseases such as Chlamydia and Gonorrhea, surge in various types of oncology diagnostics, ageing population and government’s mandate on regular screening of HPV and CT/NG. However, growth of the industry is incumbent due to ambiguity in relation to reimbursement guidelines and presence of complex regulatory framework. Global Molecular Diagnostics market is dominated by few major companies, of which Roche Holding, Novartis AG, Hologic Inc., and Qiagen NV have been covered in the report.

Spanning over 73 pages, 5 Tables and 45 Figures “Global Molecular Diagnostics Market-Focus on Infectious Diseases (HPV/Chlamydia/Gonorrhea) & Genetic Testing (HLA) - Industry Outlook 2022” report covers Executive Summary, Research Methodology, Introduction, Molecular Diagnostic Market, Global Molecualr Diagnostics Market Segmentation, Global Molecular Diagnostics Market Dynamics, Competitive Landscape, Company Profiles. This report Covered Companies - Roche Holdings, Novartis AG, Hologic Inc, Qiagen NV.

For more information Visit at: http://mrr.cm/3QY

Find all Diagnostics Reports at: http://www.marketresearchreports.com/diagnostics

Global Internet of Things (IoT) Healthcare Market Outlook 2020; New Report Launched

Internet of Things refers to ubiquitous network of interconnected objects capable of information storage and exchange through the use of embedded sensors, actuators, and other devices. The IoT is a revolutionary technology which facilitates data-driven decision making by monitoring and managing objects in real-time.

The proliferation of IoT in healthcare segment in anticipated witnessing surge in demand with use of technologically advanced medical devices. Adoption of IoT services in healthcare leads to introduction of technologically advanced connected medical devices which help in remote patient monitoring and clinical care in general. Furthermore, it provides new possibilities for personalized healthcare with the use of leading healthcare applications such as Health tracker apps, Healthcare wearable, Telemonitoring and smarthomes, Electronic health records, etc.

IoT Healthcare market can be broadly divided into three components - Medical devices, Systems & software, and Services. Software & system segment dominates global IoT Healthcare market. Some of the leading technologies facilitating integration of IoT in healthcare domain that are covered in the report are RFID, mHealth, Telemedicine and Bluetooth Low Energy. Extensive coverage on actual and forecasted market analysis of IoT Healthcare, its components and technologies are provided in the report.

Growth of the market is fueled by increasing prevalence of chronic diseases, rising number of geriatric population globally and higher efficiency provided by use of IoT in healthcare. Other factors such as availability of high speed internet and favorable government regulatory policies are also expected to boost market growth. However, certain limitations of IoT in healthcare segment poses challenge to growth of the industry. Some of these are lack of interoperability, privacy and security concerns and lack of regulatory oversight.

The report also covers section on major trends and industry developments in recent years which influences industry dynamics. Companies operating in the segment, both medical device manufacturers and IT companies are developing innovative products and services such as, Cognitive solution to diabetes management by Medtronic and IBM, Medical data exchange by Cisco and Philips Medical dispensing service, amongst others.

The report highlights key players operating in IoT healthcare market. These include Medtronic PLC, GE Healthcare and Philips Healthcare. These players have been profiled based on attributes such as business overview, product segments, financial and business strategies. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. The report includes relevant information which can be fruitful for clients in evaluating opportunities in global IoT healthcare market.

Spanning over 63 pages, 7 Tables and 23 Figures “Global Internet of Things (IoT) Healthcare Market Outlook 2020” report covers Executive Summary, Research Methodology, Internet of Things, IoT Healthcare Industry, Global IoT Healthcare Market Analysis, Global IoT Healthcare Market Segment Analysis, Global IoT Healthcare Trends & Industry Developments, Global IoT Healthcare Market Dynamics, Competitive Landscape, Company Profiles. This report Covered Companies - GE Healthcare, Medtronic PLC, Philips Healthcare.

For more information Visit at: http://mrr.cm/3QM

Find all IT and eHealth Reports at: http://www.marketresearchreports.com/it-ehealth

Future of Generic Drugs and Strategies for Commercial Success Market Report; Launched via MarketResearchReports.com

The Future of Generic Drugs and Strategies for Commercial Success discusses trends in the global generic drugs market, and the evolving business strategies being adopted and leveraged by generic drug companies around the world. Publisher conducted an extensive and targeted industry survey of experts from top global generic drug companies, to gather opinions on the trends and future commercial prospects of the generic drugs market. The findings from the survey and results from extensive data analysis and secondary research efforts have been triangulated with GBI’s own analytical views to provide an objective assessment that is comprehensive in outlook.

The generic drugs market has seen rapid expansion for more than 30 years, and consistently achieves higher annual growth rates than the overall pharmaceutical market. The increase in generic drug activity can be primarily attributed to the promise of significant revenues from blockbuster drugs nearing patent expiry. In the US – the largest generic drugs market by revenue – the number of generic drug approvals hit a record high in 2015, due to a new program that aimed to speed up approvals. There has also recently been a surge in the number of industry-transforming mergers and acquisitions, with companies looking to consolidate their position in this highly lucrative market.

The results of GBI’s latest industry survey provide insightful analyses from different expert panels, including R&D and commercial, and highlight trends observed in key geographical markets. The survey examined key commercial issues and recent developments in the generic drugs market, such as the reasons behind the surge in mergers and acquisitions, and the likely effects on market dynamics. It covered important factors currently driving or restraining the market, prospects for key therapy areas expected to exhibit significant levels of genericization in the coming years, and the most promising emerging markets for generic companies in terms of revenue potential. Additionally, the survey examined common business strategies and regulations being leveraged by global generic drug companies for market expansion.

The report covers key small molecule drugs whose patents will expire in the coming years, providing an in-depth assessment of potential generic competition, expected launch dates and the overall impact on global branded revenues to 2021. The top global generic drug companies by revenue are also examined, including financial performance and recent activity within the market.

This new report adds to our unique portfolio of trusted industry analyses, which enable our clients to assess the most promising commercial areas in the market and identify key business opportunities.

Scope

• What is the current value of the generic drugs market, and how will market dynamics change in the coming years?
• Will the US continue to dominate the market?
• Which therapy areas will witness the highest level of genericization in the next five years?
• Drivers and restraints in the generics industry:
• What are the most important factors promoting generic drug usage at a global level?
• What are the most important factors hindering or delaying generic drug approvals?
• Will governments worldwide continue their efforts to promote generic drug usage?
• How will global demographic trends impact demand for generic drugs?
• Which emerging economies are the most promising for generic drugs companies?
• Are generic drugs still negatively perceived?
• How are pricing pressures and rising costs affecting generic drug manufacturers?
• Generic drugs pipeline for top small molecule drugs in the market:
• What will be the revenue impact for key small molecule drugs whose patents expire in the near future?
• What are the key patent expiry dates for these small molecules and what level of generic competition should they expect?
• Strategies for commercial success:
• What are the most popular strategies or regulations being adopted and leveraged by generic drug manufacturers?
• What governmental policies are significantly influencing generic drug usage?
• What will be the impact of compulsory licenses in emerging markets?
• Mergers and acquisitions in the global generic drugs market:
• What are the most important factors contributing to the surge in M&A activity in the generic drugs market?
• How will market dynamics be affected by continued consolidation in the generic drugs market?
• What have been the most important transactions in the generic drugs industry in recent years?
• Top global generic drugs companies:
• How have top generic drugs companies performed in recent years?
• What are the prospects for top generic drugs companies?

Reasons to buy

This report will allow you to -

• Gain insightful analyses and understanding of market dynamics: This report comprehensively describes and assesses the most important factors driving and restraining the generic drugs market. It assesses pertinent commercial and regulatory aspects of the industry by combining survey results with proprietary in-house expertise and extensive secondary research efforts.
• Assess the generic drugs pipeline for top small molecule drugs in the market: Our study provides prospects for these drugs beyond their patent expiries, including potential generic competition, expected launch dates and revenue forecasts to 2021.
• Evaluate the strategies used by companies to promote generic drug usage: This report provides insights regarding the various commercial strategies being adopted and leveraged by generic drug companies to promote their therapies.
• Understand government policies and strategies to promote generic drug usage: This report assesses current strategies and regulations implemented by governments in key geographic markets to promote generic drug usage.
• Gain insight on mergers and acquisitions in the global generic drugs market: This report describes industry-transforming mergers and acquisitions that have occurred in recent years, the reasons behind the recent surge in these types of transactions, and their likely impact on market dynamics.

Spanning over 83 pages, 14 Tables and 45 Figures “The Future of Generic Drugs and Strategies for Commercial Success” report covers Introduction, Generic Drugs Market: Drivers and Restraints, Generic Drug Pipeline for Top Small Molecule Drugs in the Market, Strategies to Promote Generic Drug Usage by Companies, Government Policies and Strategies to Promote Generic Drug Usage, Mergers and Acquisitions in the Global Generic Drugs Market, Top Global Generic Drug Companies, Conclusion, Appendix.

For more information Visit at: http://mrr.cm/3QJ

Find all Generic Drugs Reports at: http://www.marketresearchreports.com/generic-drugs